EyeGate Pharmaceuticals (eyeg) Priced

Late-stage biotech developing a treatment for eye inflammation.

Health Care - Biotechnology

IPO Performance
Latest Trade $2.53 0.00 (0.0%)
First Day Return -15.9%
Return from IPO -70.2%
 
EyeGate Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 06/05/2015
Offer Price $8.50
Price Range $12.00 - $12.00
Offer Shares (mm) 1.2
Deal Size ($mm) 10
 
IPO Data
IPO Date 07/30/2015
Offer Price $8.50
Price Range $12.00 - $12.00
Offer Shares (mm) 1.2
Deal Size ($mm) $10
 
Underwriters
more
Business Overview
Late-stage biotech developing a treatment for eye inflammation.
Late-stage biotech developing a treatment for eye inflammation.
more
Company Data
Headquarters Waltham, MA
Founded 2004
Employees 4
Website www.eyegatepharma.com
 

Performance vs. IPO Index (IPOUSA)